Silencing the COPB2 gene decreases the proliferation, migration and invasion of human triple-negative breast cancer cells.

Experimental and Therapeutic Medicine
Wencheng WuMin Li

Abstract

Triple-negative breast cancer (TNBC) is highly invasive, has a high rate of recurrence and is associated with a poor clinical outcome when compared with non-TNBC due to a lack of effective and targeted treatments. The coatomer protein complex subunit β2 (COPB2) is upregulated in various types of malignant cancer. The present study demonstrated that COPB2 expression levels were significantly upregulated in breast carcinoma HS-578T cells (clonal cells originating from TNBC) when compared with non-TNBC MCF-7 cells. HS-578T cells also exhibited higher rates of proliferation, invasion and transendothelial migration when compared with MCF-7 cells. Moreover, it was identified that genetically silencing the COPB2 gene using a lentivirus-short hairpin RNA inhibited the proliferative, colony formation, migratory and invasive properties of the TNBC HS-578T cells. Mediation of the COPB2 silencing effect may be associated with regulating the phosphorylation of serine/threonine kinase AKT in the PI3K/AKT signaling pathway. These results suggested the importance of COPB2 in promoting the proliferation of TNBC cells and identified COPB2 as a potential novel therapeutic target.

References

Jan 1, 1995·Acta Anatomica·E D Hay
Aug 10, 2000·The British Journal of Surgery·B P WijnhovenM Pignatelli
Jan 30, 2002·Cellular and Molecular Life Sciences : CMLS·D Li, R Roberts
May 10, 2002·Nature·John F PresleyJennifer Lippincott-Schwartz
Sep 16, 2004·Nature Reviews. Molecular Cell Biology·Lynne Chang, Robert D Goldman
Oct 12, 2004·Annual Review of Cell and Developmental Biology·Marcus C S LeeRandy Schekman
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Sep 26, 2007·Cancer Science·Shinobu UmemuraYutaka Tokuda
Mar 20, 2008·Nature Clinical Practice. Oncology·Eva A TurleyMina J Bissell
May 8, 2008·Clinical & Experimental Metastasis·T BlickE W Thompson
Feb 18, 2009·World Journal of Gastroenterology : WJG·Ke LiQing-Xia Fan
Jul 28, 2009·FEBS Letters·R BeckD Cassel
Nov 5, 2010·Cold Spring Harbor Perspectives in Biology·Charles M Perou, Anne-Lise Børresen-Dale
Nov 12, 2010·The New England Journal of Medicine·William D FoulkesJorge S Reis-Filho
Nov 7, 2012·Journal of Dental Research·C S ScanlonN J D'Silva
Mar 7, 2018·European Review for Medical and Pharmacological Sciences·Z-S LiQ Huang
May 24, 2019·Journal of Cellular and Molecular Medicine·Adheesh BhandariDuping Huang
Jun 4, 2019·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu· National Health Commission Of The People's Republic Of China
Nov 12, 2019·CNS Neuroscience & Therapeutics·Yan ZhouXiao-Bing Jiang
Dec 10, 2019·Bioscience, Biotechnology, and Biochemistry·Yingzi ZhangGuanmei Zhu
Jul 4, 2020·Bioscience, Biotechnology, and Biochemistry·Xiaolin WangWenping Zhang

❮ Previous
Next ❯

Software Mentioned

R
GraphPad Prism
SPSS
ImageJ

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.